| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
2 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-01-06 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The Update on Commercial Rollout of CompuFlo® Epidural System |
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today
today provided the update on commercial rollout of CompuFlo® Epidural System.
The Board of Directors of the Issuer is pleased to report that the Company is gaining
traction with its CompuFlo® Epidural System. Specifically, the Company announced it
has begun selling CompuFlo® disposables to the University of Texas Medical Branch
at Galveston _UTMB_, an institution of the University of Texas System and agency of
the State of Texas. The Board of Directors of the Issuer anticipates adding additional
hospitals during the first quarter of 2021 and remains steadfast in its goal of establishing
the CompuFlo® Epidural System as the new standard of care in epidural anesthesia.
Given the strong cash position at the end of the third quarter of its parent, The
Board of Directors of the Issuer believes that the Company is well funded to support
its sales and marketing activities around the CompuFlo® Epidural System and have no
plans to raise capital for the foreseeable future.
|
|
|
RB_ASO: The Update on Commercial Rollout of CompuFlo® Epidural System 
